vs
丹纳赫(DHR)与LPL Financial Holdings Inc.(LPLA)财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是LPL Financial Holdings Inc.的1.2倍($6.0B vs $4.9B),丹纳赫净利率更高(17.3% vs 6.1%,领先11.2%),LPL Financial Holdings Inc.同比增速更快(40.4% vs 3.7%),丹纳赫自由现金流更多($1.1B vs $613.3M),过去两年LPL Financial Holdings Inc.的营收复合增速更高(32.0% vs 1.8%)
丹纳赫是总部位于美国华盛顿特区的医疗健康企业,聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块:生物技术板块开发治疗相关产品,生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产,诊断板块研发检测仪器,为全球生命健康产业提供核心支持。
LPL Financial Holdings Inc.成立于1989年,是美国规模最大的独立经纪自营商。截至2021年,公司拥有超17500名财务顾问,咨询及经纪类资产规模超1万亿美元,2023财年总营收约103亿美元,在波士顿、福特米尔、奥斯汀、圣迭戈设有核心办事处,是FINRA和SIPC成员。
DHR vs LPLA — 直观对比
营收规模更大
DHR
是对方的1.2倍
$4.9B
营收增速更快
LPLA
高出36.8%
3.7%
净利率更高
DHR
高出11.2%
6.1%
自由现金流更多
DHR
多$471.7M
$613.3M
两年增速更快
LPLA
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $6.0B | $4.9B |
| 净利润 | $1.0B | $300.7M |
| 毛利率 | 60.3% | — |
| 营业利润率 | 22.6% | 8.1% |
| 净利率 | 17.3% | 6.1% |
| 营收同比 | 3.7% | 40.4% |
| 净利润同比 | 7.9% | 11.1% |
| 每股收益(稀释后) | $1.45 | $3.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DHR
LPLA
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $4.9B | ||
| Q3 25 | $6.1B | $4.6B | ||
| Q2 25 | $5.9B | $3.8B | ||
| Q1 25 | $5.7B | $3.7B | ||
| Q4 24 | $6.5B | $3.5B | ||
| Q3 24 | $5.8B | $3.1B | ||
| Q2 24 | $5.7B | $2.9B |
净利润
DHR
LPLA
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $300.7M | ||
| Q3 25 | $908.0M | $-29.5M | ||
| Q2 25 | $555.0M | $273.2M | ||
| Q1 25 | $954.0M | $318.6M | ||
| Q4 24 | $1.1B | $270.7M | ||
| Q3 24 | $818.0M | $255.3M | ||
| Q2 24 | $907.0M | $243.8M |
毛利率
DHR
LPLA
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | — | ||
| Q3 25 | 58.2% | — | ||
| Q2 25 | 59.3% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 59.5% | — | ||
| Q3 24 | 58.7% | — | ||
| Q2 24 | 59.7% | — |
营业利润率
DHR
LPLA
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 8.1% | ||
| Q3 25 | 19.1% | -0.7% | ||
| Q2 25 | 12.8% | 9.6% | ||
| Q1 25 | 22.2% | 11.4% | ||
| Q4 24 | 21.8% | 9.7% | ||
| Q3 24 | 16.5% | 11.2% | ||
| Q2 24 | 20.3% | 11.3% |
净利率
DHR
LPLA
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 6.1% | ||
| Q3 25 | 15.0% | -0.6% | ||
| Q2 25 | 9.3% | 7.1% | ||
| Q1 25 | 16.6% | 8.7% | ||
| Q4 24 | 16.6% | 7.7% | ||
| Q3 24 | 14.1% | 8.2% | ||
| Q2 24 | 15.8% | 8.3% |
每股收益(稀释后)
DHR
LPLA
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $3.65 | ||
| Q3 25 | $1.27 | $-0.37 | ||
| Q2 25 | $0.77 | $3.40 | ||
| Q1 25 | $1.32 | $4.24 | ||
| Q4 24 | $1.50 | $3.58 | ||
| Q3 24 | $1.12 | $3.39 | ||
| Q2 24 | $1.22 | $3.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1B |
| 总债务越低越好 | — | $7.3B |
| 股东权益账面价值 | — | $5.3B |
| 总资产 | — | $18.5B |
| 负债/权益比越低杠杆越低 | — | 1.36× |
8季度趋势,按日历期对齐
现金及短期投资
DHR
LPLA
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $4.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.4B |
总债务
DHR
LPLA
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $7.3B | ||
| Q3 25 | $16.9B | $7.5B | ||
| Q2 25 | $17.4B | $7.2B | ||
| Q1 25 | $16.5B | $5.7B | ||
| Q4 24 | $16.0B | $5.5B | ||
| Q3 24 | $17.5B | $4.4B | ||
| Q2 24 | $17.0B | $4.4B |
股东权益
DHR
LPLA
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $5.3B | ||
| Q3 25 | $51.1B | $5.0B | ||
| Q2 25 | $52.3B | $5.1B | ||
| Q1 25 | $50.8B | $3.1B | ||
| Q4 24 | $49.5B | $2.9B | ||
| Q3 24 | $51.3B | $2.8B | ||
| Q2 24 | $49.9B | $2.5B |
总资产
DHR
LPLA
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $18.5B | ||
| Q3 25 | $79.9B | $18.0B | ||
| Q2 25 | $81.6B | $17.5B | ||
| Q1 25 | $79.1B | $14.0B | ||
| Q4 24 | $77.5B | $13.3B | ||
| Q3 24 | $80.6B | $11.9B | ||
| Q2 24 | $78.6B | $11.5B |
负债/权益比
DHR
LPLA
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 1.36× | ||
| Q3 25 | 0.33× | 1.49× | ||
| Q2 25 | 0.33× | 1.41× | ||
| Q1 25 | 0.32× | 1.82× | ||
| Q4 24 | 0.32× | 1.87× | ||
| Q3 24 | 0.34× | 1.60× | ||
| Q2 24 | 0.34× | 1.77× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.3B | $785.0M |
| 自由现金流经营现金流 - 资本支出 | $1.1B | $613.3M |
| 自由现金流率自由现金流/营收 | 18.2% | 12.4% |
| 资本支出强度资本支出/营收 | 4.0% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.28× | 2.61× |
| 过去12个月自由现金流最近4个季度 | $5.3B | $-981.8M |
8季度趋势,按日历期对齐
经营现金流
DHR
LPLA
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $785.0M | ||
| Q3 25 | $1.7B | $-1.7B | ||
| Q2 25 | $1.3B | $193.3M | ||
| Q1 25 | $1.3B | $339.8M | ||
| Q4 24 | $2.0B | $-178.8M | ||
| Q3 24 | $1.5B | $209.3M | ||
| Q2 24 | $1.4B | $-178.9M |
自由现金流
DHR
LPLA
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $613.3M | ||
| Q3 25 | $1.4B | $-1.9B | ||
| Q2 25 | $1.1B | $56.3M | ||
| Q1 25 | $1.1B | $220.3M | ||
| Q4 24 | $1.5B | $-344.3M | ||
| Q3 24 | $1.2B | $62.3M | ||
| Q2 24 | $1.1B | $-307.8M |
自由现金流率
DHR
LPLA
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | 12.4% | ||
| Q3 25 | 22.6% | -41.1% | ||
| Q2 25 | 18.4% | 1.5% | ||
| Q1 25 | 18.4% | 6.0% | ||
| Q4 24 | 23.0% | -9.8% | ||
| Q3 24 | 21.0% | 2.0% | ||
| Q2 24 | 19.7% | -10.5% |
资本支出强度
DHR
LPLA
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 3.5% | ||
| Q3 25 | 4.8% | 3.1% | ||
| Q2 25 | 4.2% | 3.6% | ||
| Q1 25 | 4.3% | 3.3% | ||
| Q4 24 | 7.9% | 4.7% | ||
| Q3 24 | 5.1% | 4.7% | ||
| Q2 24 | 5.0% | 4.4% |
现金转化率
DHR
LPLA
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 2.61× | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | 2.41× | 0.71× | ||
| Q1 25 | 1.36× | 1.07× | ||
| Q4 24 | 1.86× | -0.66× | ||
| Q3 24 | 1.85× | 0.82× | ||
| Q2 24 | 1.56× | -0.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图